RITI®, TEST TO ASSIST IN THE PRESCRIPTION OF BIOLOGICS IN AUTOIMMUNE DISEASES.

Biologics have revolutionized how autoimmune diseases are treated. These new generation drugs are highly effective and have the power to alleviate pain and put the disease into remission.

Sustainable remission is characterized by the absence of symptoms and a significant reduction in inflammatory activity in the joints. It must be obtained quickly, particularly at the beginning of the disease, to prevent joint complications as much as possible in the short and medium term. 

Among the therapeutic arsenal of biologics, there is no tool to help physicians rationalize their choice of prescription.  

Consequences

  • Patient suffering
  • Weakened immune system
  • The disease spreads

Based on these observations, mYXpression has developed RITI®, 1st test to assist in the prescription of the most adapted biologics according to the patient's biology.

RITI® Objective : maximize the chances of remission

For each biologics, the RITI® test provides an efficacy score based on the patient's biological profile. Thanks to RITI®, the physician has access to all scientific information concerning her/his patient, both biological and pharmacological.

 Rheumatoid arthritis is the first field of application for the RITI® test.

How does RITI® work ?

Based on messenger RNA sequencing from a patient's blood sample, an efficacy score is generated for each existing biologics for the intended use.

Targeted biotherapies in the RITI® test report for rheumatoid arthritis